Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    y-52-52120-148
Show Display Options
Rank Status Study
1 Completed Dysport® Adult Upper Limb Spasticity Extension Study
Condition: Nervous System Disorders
Intervention: Drug: Botulinum type A toxin (Dysport®)

Study has passed its completion date and status has not been verified in more than two years.